Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Precision Medicine for Advanced Solid Malignancies Based on Circulating Tumor DNA Analysis].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Dec 2020

Ishii Takahiro, Nakamura Yoshiaki

Abstract excerpt

Cancer precision medicine has become widespread in the world. In Japan, genomic profiling tumor tissues using next generation sequencing(NGS)has been reimbursed to enable simultaneous measurement of multiple biomarkers and genomic abnormalities in clinical practice. However, NGS analysis of tumor tissue has several problems, including long turnaround time, and difficulty in capturing heterogeneity and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Precision Medicine

Source

Identifiers

PMID: 33342975

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Precision Medicine for Advanced Solid Malignancies Based on Circulating Tumor DNA Analysis].PMID 33342975Read ↗

[Clinical Utility of Circulating Tumor DNA Analysis for Precision Medicine in Patients with Advanced Gastrointestinal Cancer].Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of CancerSemantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

Circulating tumor DNA: current challenges for clinical utility.Semantic proximity Read ↗

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsSemantic proximity Read ↗

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity Read ↗

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.Semantic proximity Read ↗

Circulating Tumor DNA as a Liquid Biopsy for CancerSemantic proximity Read ↗

Clinical Circulating Tumor DNA Testing for Precision Oncology.Semantic proximity Read ↗

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection TechniquesSemantic proximity Read ↗

"Liquid biopsy"-ctDNA detection with great potential and challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.